| Drug | Class | Adult | Paediatric | Notes |
|---|---|---|---|---|
| Nitrofurantoin (uncomplicated cystitis)[1] | Furan antimicrobial | 100 mg PO BD × 5 days | ≥3 months: 5–7 mg/kg/day | First-line for uncomplicated cystitis; effective concentration only in urine; avoid eGFR <30 (insufficient excretion); pulmonary fibrosis with prolonged use; safe in pregnancy except at term |
| Fosfomycin (uncomplicated cystitis)[1] | Phosphonic acid antimicrobial | 3 g PO single dose (sachet dissolved in water) | — | Single-dose convenience for uncomplicated cystitis; resistance increasing; useful in suspected ESBL pathogen |
| Co-trimoxazole (uncomplicated cystitis)[1] | Sulfonamide + trimethoprim | 160/800 mg PO BD × 3 days | 8/40 mg/kg/day in 2 divided doses | Use only where local E. coli resistance <20%; avoid in pregnancy near term, G6PD, severe renal impairment |
| Co-amoxiclav (alternative cystitis)[1] | Aminopenicillin + beta-lactamase inhibitor | 625 mg PO TDS × 5 days | 20–40 mg/kg/day amoxicillin component | Useful in penicillin-tolerant; rising resistance; check local antibiogram |
| Ceftriaxone (pyelonephritis or complicated UTI)[1] | Third-generation cephalosporin | 1–2 g IV daily; switch to oral cefuroxime 500 mg BD or per culture × total 10–14 days | 50–80 mg/kg/day IV | First-line for pyelonephritis or complicated UTI requiring IV; switch to oral by culture sensitivity at 48–72 h |
| Piperacillin-tazobactam or meropenem (severe complicated UTI)[1] | Beta-lactam ± beta-lactamase inhibitor / carbapenem | Piperacillin-tazobactam 4.5 g IV every 6–8 h; meropenem 1 g IV every 8 h | Per local protocol | Severe complicated UTI, sepsis, ESBL or AmpC concern; renal dose adjustment; reassess at 48 h with cultures |
| Vaginal estrogen (postmenopausal recurrent UTI)[1] | Local estrogen | Estradiol 25 µg pessary or 0.1 mg cream nightly × 2 weeks then 2× weekly | — | First-line non-antibiotic prevention in postmenopausal women; minimal systemic absorption; safe with most contraindications to systemic HRT |
Diagnosis and stewardship-focused antimicrobial management of uncomplicated and complicated UTI in adults.